Evidence map›Paper›PMID 35606169›Full record

Observational studySeminars in oncology2022

The impact of the COVID-19 pandemic on tertiary care cancer center: Analyzing administrative data.

Guilherme Jorge Costa, Hélio de Araújo Fonseca Júnior, Fábio Costa Malta, Felipe Costa Leandro Bitu, Claudia Barbosa, Josenildo de Sá, André Amarante, Luiz Claudio Santos Thuler

Abstract readObservational Study
In one paragraph

Observational study in Seminars in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guilherme Jorge CostaDepartment of Research and Education, Hospital de Câncer de Pernambuco, Recife, Pernambuco, Brazil. Electronic address: guibacosta03@gmail.com.
Hélio de Araújo Fonseca JúniorChief Executive Officer, Hospital de Câncer de Pernambuco, Recife, Pernambuco, Brazil.
Fábio Costa MaltaMedical Director, Hospital de Câncer de Pernambuco, Recife, Pernambuco, Brazil.
Felipe Costa Leandro BituMangement Director, Hospital de Câncer de Pernambuco, Recife, Pernambuco, Brazil.
Claudia BarbosaAdministrative Director, Hospital de Câncer de Pernambuco, Recife, Pernambuco, Brazil.
Josenildo de SáControllership Director, Hospital de Câncer de Pernambuco, Recife, Pernambuco, Brazil.
André AmaranteFinancial Director, Hospital de Câncer de Pernambuco, Recife, Pernambuco, Brazil.
Luiz Claudio Santos ThulerClinical Epidemiology Program, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatients with cancer need to receive their proper treatment and often cannot wait for their treatment, despite delays due to the COVID-19 pandemic. As a result, many cancer centers have had challenges maintaining their oncological activities.

objectivesTo compare the average hospital management data and indicators in two different periods, with and without the peak of COVID-19 cases, from an important tertiary cancer center in the northeast region of Brazil.

methodsA retrospective and observational study was performed comparing average hospital administrative data and indicators, between January to March v April to June, 2020 exclusively at the Hospital de Câncer de Pernambuco, Brazil.

resultsThere were on average a 13% reduction in the chemotherapy administered (P = .131), 17% fewer radiotherapy treatments carried out (P = .043) and 41% as many oncologic surgeries undertaken (P = .002). There was a reduction in the number of sessions of out-patient chemotherapy of 8•6% (P = .271) and chemotherapy inpatients of 33% (P = .038). Admission of new cases of patients with cancer was reduced by 44% (P = .007) during the period analyzed. Ambulatory appointments also decreased by 55% (P = .004) and emergency room appointments fell by 7•9% (P = .495). The number of hospitalizations was reduced by 36% (P = .005) and the occupancy rate decreased by 23•6% (P = .003), while the length of individual hospital stays (in days) increased 10•5% (P = .116).

conclusionWe report a reduction in the number of radiotherapy treatments and surgeries performed cancer carried out, ambulatory and emergency appointments, hospitalization and admission of new cases of cancer during peak of COVID-19 in an important public tertiary cancer center in the northeast region of Brazil.

Indexed as

COVID-19NeoplasmsHumansPandemicsRetrospective StudiesSARS-CoV-2Tertiary Health CareCancerCOVID-19HospitalIndicatorManagement

Identifiers

PMID35606169
PMCPMC9010229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.